People · Operator
Named in public records as an officer, director or promoter · active 2015–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Fulgent Therapeutics LLC | — | Biotechnology | Series B | $29.4M | $1.1B | 2015 |
| Fulgent Pharma LLC | — | Biotechnology | Series A | $5.4M | $195.2M | 2016 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.